Ipatasertib, an oral AKT inhibitor, in combination with paclitaxel exhibits anti-proliferative and anti-tumorigenic effects in preclinical studies for endometrioid endometrial cancer: Endometrial cancer molecularly targeted therapy consortium (227)
Gynecologic Oncology（2022）
关键词
endometrial cancer,endometrioid endometrial cancer,endometrial cancer molecularly,oral akt inhibitor,paclitaxel,anti-proliferative,anti-tumorigenic
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要